Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
2018 · Annals of Oncology · 839 citations
https://doi.org/10.1093/annonc/mdy155